We are live on ! Find out more
MCIM

Meadow Creek Investment Management Portfolio holdings

AUM $5.09B
1-Year Est. Return 5.82%
This Fund
S&P 500
This Quarter Est. Return
+4.62%
1 Year Est. Return
+5.82%
3 Year Est. Return
+54.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.03B
AUM Growth
+$118M
Cap. Flow
-$50.5M
Cap. Flow %
-1%
Top 10 Hldgs %
23.21%
Holding
1,391
New
49
Increased
502
Reduced
319
Closed
40

Top Buys

Rank Stock Value
1
WAB icon
Wabtec
WAB
+$19.8M
2
LYB icon
LyondellBasell Industries
LYB
+$11.7M
3
MSFT icon
Microsoft
MSFT
+$11.5M
4
CMCSA icon
Comcast
CMCSA
+$11M
5
DAL icon
Delta Air Lines
DAL
+$9.78M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$23.8M
2
CELG
Celgene Corp
CELG
+$22.9M
3
INTC icon
Intel
INTC
+$15.9M
4
PYPL icon
PayPal
PYPL
+$9.32M
5
NKE icon
Nike
NKE
+$9.14M

Sector Composition

Rank Sector Weight
1 Technology 18.56%
2 Financials 15.29%
3 Healthcare 13.26%
4 Consumer Discretionary 12.8%
5 Communication Services 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BOX icon
1326
Box
BOX
$4.47B
$19K ﹤0.01%
1,064
– –
AGIO icon
1327
Agios Pharmaceuticals
AGIO
$2B
$18K ﹤0.01%
364
-5,124
-93% -$274K
BB icon
1328
BlackBerry
BB
$5.24B
$18K ﹤0.01%
2,552
+528
+26% +$4.58K
MEOH icon
1329
Methanex
MEOH
$4.17B
$18K ﹤0.01%
418
+22
+6% +$1.1K
NTNX icon
1330
Nutanix
NTNX
$17.2B
$18K ﹤0.01%
714
-1,530
-68% -$53.3K
SGMO
1331
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$18K ﹤0.01%
+1,680
New +$17.9K
BBIO icon
1332
BridgeBio Pharma
BBIO
$16.4B
$17K ﹤0.01%
+616
New +$16.8K
FIVN icon
1333
FIVE9
FIVN
$2.35B
$17K ﹤0.01%
336
– –
AZPN
1334
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$16K ﹤0.01%
132
-462
-78% -$56K
GDDY icon
1335
GoDaddy
GDDY
$11.3B
$14K ﹤0.01%
192
– –
ECOM
1336
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$14K ﹤0.01%
1,652
– –
KALV
1337
DELISTED
KalVista Pharmaceuticals
KALV
$13K ﹤0.01%
608
– –
TRQ
1338
DELISTED
Turquoise Hill Resources Ltd
TRQ
$13K ﹤0.01%
1,086
+70
+7% +$968
AKRO
1339
DELISTED
Akero Therapeutics
AKRO
$12K ﹤0.01%
+616
New +$11.7K
DNLI icon
1340
Denali Therapeutics
DNLI
$3.97B
$12K ﹤0.01%
594
– –
VCIT icon
1341
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.7B
$12K ﹤0.01%
136
– –
CBAY
1342
DELISTED
Cymabay Therapeutics
CBAY
$9K ﹤0.01%
1,264
– –
CRNX icon
1343
Crinetics Pharmaceuticals
CRNX
$8.96B
$8K ﹤0.01%
340
– –
AQST icon
1344
Aquestive Therapeutics
AQST
$537M
$7K ﹤0.01%
1,696
– –
CYCN icon
1345
Cyclerion Therapeutics
CYCN
$16.9M
$7K ﹤0.01%
+32
New +$9.06K
TBPH icon
1346
Theravance Biopharma
TBPH
$880M
$6K ﹤0.01%
352
– –
ESLT icon
1347
Elbit Systems
ESLT
$36.9B
$5K ﹤0.01%
32
– –
CLDR
1348
DELISTED
Cloudera, Inc.
CLDR
$5K ﹤0.01%
992
– –
PTE
1349
DELISTED
PolarityTE, Inc. Common Stock
PTE
$1K ﹤0.01%
4
– –
ARD
1350
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$1K ﹤0.01%
+84
New +$1.23K
52 53
54
55 56

Similar funds

FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
GHCM
Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return
EP
Elkfork Partners Portland, Oregon $4.11B AUM 5.26% 1-Year Est. Return
MIH
Madison Investment Holdings Madison, Wisconsin $6.16B AUM 11.67% 1-Year Est. Return
FCM
Flinton Capital Management Philadelphia, Pennsylvania $3.22B AUM 4.75% 1-Year Est. Return
NA
Neuburgh Advisers Los Angeles, California $3.22B AUM 3.74% 1-Year Est. Return
TAM
Tyers Asset Management Austin, Texas $3.02B AUM 5.29% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Meadow Creek Investment Management's Q2 2019 Portfolio in Review

As of Q2 2019, Meadow Creek Investment Management held 1,391 positions worth $5.03B, up 2.4% from $4.91B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Meadow Creek Investment Management's Q2 2019 filing shows 49 new, 502 increased, 319 reduced and 40 closed positions. Its largest new stake was L3Harris: 39,592 shares worth $7.49M. The largest sale was Linde, an estimated $23.8M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

  • Meadow Creek Investment Management's largest Q2 2019 buy was L3Harris: 39,592 shares worth $7.49M.
  • Meadow Creek Investment Management added most to Wabtec in Q2 2019, an estimated $19.8M increase.
  • Meadow Creek Investment Management's biggest Q2 2019 reduction was Linde, cutting an estimated $23.8M.
  • Meadow Creek Investment Management fully exited Anadarko Petroleum in Q2 2019, selling an estimated $2.63M.
  • Meadow Creek Investment Management's ten largest holdings make up 23% of its $5.03B portfolio in Q2 2019.
  • Meadow Creek Investment Management opened 49 new positions and closed 40 in Q2 2019.
  • Meadow Creek Investment Management's portfolio value rose 2.4% quarter-over-quarter to $5.03B.

Based on Meadow Creek Investment Management's 13F filing for Q2 2019, filed 13 Aug 2019.